← FDA Drug Approvals (Drugs@FDA)

ROMIDEPSIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2026-06-02

Drug application

FDA Application #

ANDA219099

Application type

Abbreviated New Drug Application (Generic)

Brand name

ROMIDEPSIN

Generic name

ROMIDEPSIN

Active ingredients

ROMIDEPSIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

AMNEAL

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2026-06-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown